Gender-Specific Aspects in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: A Single-Center Experience

Doris Posch; Werner Rabitsch; Philipp Wohlfarth; Michael Leiner; Edit Porpaczy; Johannes Drach; Markus Raderer; Wolfgang Lamm

doi:10.1159/000478265

Gender-Specific Aspects in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: A Single-Center Experience

Oncology ◽

10.1159/000478265 ◽

2017 ◽

Vol 93 (5) ◽

pp. 295-301

Author(s):

Doris Posch ◽

Werner Rabitsch ◽

Philipp Wohlfarth ◽

Michael Leiner ◽

Edit Porpaczy ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Single Center ◽

Single Center Experience ◽

Gender Specific

Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 Years

Transplantation Proceedings ◽

10.1016/j.transproceed.2015.12.031 ◽

2016 ◽

Vol 48 (1) ◽

pp. 177-184 ◽

Cited By ~ 10

Author(s):

P. Remenyi ◽

G. Varga ◽

G. Mikala ◽

M. Reti ◽

L. Gopcsa ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Single Center ◽

Single Center Experience

Effect of melphalan 140 mg/m2vs 200 mg/m2on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experience

Clinical Transplantation ◽

10.1111/ctr.12762 ◽

2016 ◽

Vol 30 (8) ◽

pp. 894-900 ◽

Cited By ~ 2

Author(s):

Lakshmikanth Katragadda ◽

Lindsay M. McCullough ◽

Yunfeng Dai ◽

Jack Hsu ◽

Michael Byrne ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Single Center ◽

Single Center Experience

Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience

Supportive Care in Cancer ◽

10.1007/s00520-021-06472-7 ◽

2021 ◽

Author(s):

Barbara Loteta ◽

Annalisa Paviglianiti ◽

Virginia Naso ◽

Anna Ferreri ◽

Tiziana Moscato ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Nausea And Vomiting ◽

High Dose ◽

Single Center ◽

Single Center Experience ◽

High Dose Melphalan

Single Center Experience with Autologous Stem Cell Transplantation for Multiple Myeloma: A Retrospective Analysis

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2017.03.130 ◽

2017 ◽

Vol 17 (1) ◽

pp. e72

Author(s):

Jeevan Kumar ◽

Reena Nair ◽

Anupam Chakrapani ◽

Saurabh Jayant Bhave ◽

Sisir Patra ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Retrospective Analysis ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Single Center ◽

Single Center Experience

Poor Outcomes for IgD Multiple Myeloma Patients Following High-Dose Melphalan and Autologous Stem Cell Transplantation: A Single Center Experience

Journal of Korean Medical Science ◽

10.3346/jkms.2008.23.5.819 ◽

2008 ◽

Vol 23 (5) ◽

pp. 819 ◽

Cited By ~ 6

Author(s):

Yong Pil Chong ◽

Shin Kim ◽

Ok Bae Ko ◽

Ja Eun Koo ◽

Danbi Lee ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

High Dose ◽

Single Center ◽

Single Center Experience ◽

Poor Outcomes ◽

High Dose Melphalan

Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2017.12.009 ◽

2018 ◽

Vol 18 (3) ◽

pp. 225-234 ◽

Cited By ~ 1

Author(s):

Henry Chan ◽

Madeline Phillips ◽

Manjula Maganti ◽

Sophia Farooki ◽

Giovanni Piza Rodriguez ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Single Center ◽

Single Center Experience

Poster: MM-254: Autologous Hematopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma as a Standard Therapeutic Procedure. Is it Feasible? Single Center Experience

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01592-5 ◽

2021 ◽

Vol 21 ◽

pp. S254

Author(s):

Lazar Chadievski ◽

Irina Panovska Stavridis ◽

Borce Georgievski ◽

Lidija Chevreska ◽

Sanja Trajkova ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Elderly Patients ◽

Cell Transplantation ◽

Therapeutic Procedure ◽

Single Center ◽

Hematopoietic Stem ◽

Single Center Experience

DHAP plus filgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory lymphoma: A single center experience

Transfusion and Apheresis Science ◽

10.1016/j.transci.2016.01.012 ◽

2016 ◽

Vol 54 (1) ◽

pp. 48-52

Author(s):

Ilhami Berber ◽

Mehmet Ali Erkurt ◽

Irfan Kuku ◽

Emin Kaya ◽

Harika Gozukara Bag ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Stem Cell Mobilization ◽

Single Center ◽

Peripheral Stem Cell ◽

Single Center Experience ◽

Refractory Lymphoma ◽

Cell Mobilization

Safety and Toxicities of Radiotherapy As Consolidation or Cytoreduction Around the Time of Autologous Stem Cell Transplantation for Multiple Myeloma Patients: A Single Center Retrospective Report

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2018.12.833 ◽

2019 ◽

Vol 25 (3) ◽

pp. S413-S414

Author(s):

Noam E. Kopmar ◽

Yolanda D. Tseng ◽

Leona A. Holmberg ◽

Pamela S. Becker ◽

Damian J. Green ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Single Center ◽

Retrospective Report

Autologous stem cell transplantation (ASCT) is safe and effective for the treatment of non-hodgkin lymphoma (NHL) in an elderly population of patients over 65 years old: A single center experience

Annals of Oncology ◽

10.1093/annonc/mdx373.022 ◽

2017 ◽

Vol 28 ◽

pp. v363

Author(s):

M.P. Tardy ◽

J. Viotti ◽

A. Boscagli Melaine ◽

A. Thyss ◽

F. Peyrade ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Elderly Population ◽

Single Center ◽

Single Center Experience ◽

Non Hodgkin Lymphoma